The BRCA1-Δ11q alternative splice isoform bypasses germline mutations and promotes therapeutic resistance to PARP inhibition and cisplatin
kConFab Investigators
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'The BRCA1-Δ11q alternative splice isoform bypasses germline mutations and promotes therapeutic resistance to PARP inhibition and cisplatin'. Together they form a unique fingerprint.